Technical Analysis for SRNE - Sorrento Therapeutics, Inc.

Grade Last Price % Change Price Change
grade D 3.75 36.36% 1.00
SRNE closed up 18.03 percent on Monday, March 18, 2019, on 1.91 times normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical SRNE trend table...

Date Alert Name Type % Chg
Mar 18 180 Bullish Setup Bullish Swing Setup 36.36%
Mar 18 Expansion Breakout Bullish Swing Setup 36.36%
Mar 18 Reversal New Highs Setup Bullish Swing Setup 36.36%
Mar 18 Wide Range Bar Range Expansion 36.36%
Mar 18 Upper Bollinger Band Walk Strength 36.36%
Mar 18 Earnings Movers Other 36.36%
Mar 18 Weak + Overbought Other 36.36%
Mar 18 Outside Day Range Expansion 36.36%
Mar 18 Wide Bands Range Expansion 36.36%
Mar 18 Above Upper BB Strength 36.36%

Older signals for SRNE ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Sorrento Therapeutics, Inc., a development stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel and proprietary biotherapeutics for the treatment of cancer, inflammation, metabolic, and infectious diseases in the United States. The company's G-MAB, a human antibody library platform, facilitates the rapid identification and isolation of highly specific antibody therapeutic product candidates that bind to disease targets appropriate for antibody therapy. Its human antibody library technology is used to construct large human antibody libraries. It has license agreement with OPKO Health, Inc. to develop, manufacture, use, market, sell, offer to sell, import, and export certain products related to the development, manufacture, marketing, and sale of drugs for ophthalmological indications. Sorrento Therapeutics, Inc. is based in San Diego, California.
Medicine Health Biotechnology Biopharmaceutical Cancer Biology Immunology Disease Infectious Diseases Treatment Of Cancer Immune System Inflammation Antibody Monoclonal Antibody Antibody Therapy
Is SRNE a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 8.45
52 Week Low 1.8
Average Volume 1,623,148
200-Day Moving Average 4.1455
50-Day Moving Average 2.2336
20-Day Moving Average 2.1535
10-Day Moving Average 2.192
Average True Range 0.1847
ADX 16.83
+DI 33.4353
-DI 12.2804
Chandelier Exit (Long, 3 ATRs ) 2.2259
Chandelier Exit (Short, 3 ATRs ) 2.3541
Upper Bollinger Band 2.56
Lower Bollinger Band 1.747
Percent B (%b) 1.23
BandWidth 37.752496
MACD Line 0.053
MACD Signal Line -0.0231
MACD Histogram 0.0761
Fundamentals Value
Market Cap 189.67 Million
Num Shares 69 Million
EPS -0.66
Price-to-Earnings (P/E) Ratio -4.18
Price-to-Sales 10.91
Price-to-Book 1.87
PEG Ratio -0.06
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.46
Resistance 3 (R3) 3.39 3.08 3.34
Resistance 2 (R2) 3.08 2.90 3.12 3.30
Resistance 1 (R1) 2.92 2.79 3.00 2.99 3.26
Pivot Point 2.61 2.61 2.66 2.65 2.61
Support 1 (S1) 2.45 2.43 2.53 2.52 2.24
Support 2 (S2) 2.14 2.32 2.18 2.20
Support 3 (S3) 1.98 2.14 2.16
Support 4 (S4) 2.05